Diacerein (DAR) is a pro-drug that undergoes hydrolysis into Rhein (Rh); complexation with Cyclodextrins has been suggested to modulate DAR degradation rate. In this work, the effect of hydroxypropyl derivate of β-Cyclodextrin (HPβCD) complexation on the DAR hydrolysis has been investigated. As for DAR stability in cyclodextrin complexes, a decrease in the hydrolysis rate constant (Kc) with increasing cyclodextrin concentration has been observed (0.23 h-1 vs 0.11 h-1 for free drug and for 100 mM HPβCD, respectively). A stability constant (Xst) of DAR/HPpCD complex of 50 M-1 was obtained by the kinetic data. Such a value was compared with those obtained by Benesi-Hildebrand equation applied to spectroscopic measurements, HPLC method and Phase Solubility studies. The influence of complexation technique on aqueous solubility and dissolution rate profiles was also assessed. For this purpose solid complexes are prepared by freeze drying, co-evaporation, and kneading techniques. The results, obtained by UV-Vis spectroscopy analysis, have been compared with those obtained for the physical mixture. Eventually, selective physicochemical determinations based on differential scanning calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FT-IR) were used to characterize the complexes. © 2011, AIDIC Servizi S.r.l.

Petralito, S., Zanardi, I., Memoli, A., Annesini, M.C., Travagli, V. (2011). Cyclodextrin/diacerein inclusion complex: a tool for therapeutic drug delivery. In S. Pierucci (a cura di), Chemical Engineering Transactions (pp. 967-972). Milano : AIDIC SERVIZI SRL [10.3303/CET1124162].

Cyclodextrin/diacerein inclusion complex: a tool for therapeutic drug delivery

Zanardi, Iacopo;Travagli, Valter
2011-01-01

Abstract

Diacerein (DAR) is a pro-drug that undergoes hydrolysis into Rhein (Rh); complexation with Cyclodextrins has been suggested to modulate DAR degradation rate. In this work, the effect of hydroxypropyl derivate of β-Cyclodextrin (HPβCD) complexation on the DAR hydrolysis has been investigated. As for DAR stability in cyclodextrin complexes, a decrease in the hydrolysis rate constant (Kc) with increasing cyclodextrin concentration has been observed (0.23 h-1 vs 0.11 h-1 for free drug and for 100 mM HPβCD, respectively). A stability constant (Xst) of DAR/HPpCD complex of 50 M-1 was obtained by the kinetic data. Such a value was compared with those obtained by Benesi-Hildebrand equation applied to spectroscopic measurements, HPLC method and Phase Solubility studies. The influence of complexation technique on aqueous solubility and dissolution rate profiles was also assessed. For this purpose solid complexes are prepared by freeze drying, co-evaporation, and kneading techniques. The results, obtained by UV-Vis spectroscopy analysis, have been compared with those obtained for the physical mixture. Eventually, selective physicochemical determinations based on differential scanning calorimetry (DSC) and Fourier Transform Infrared Spectroscopy (FT-IR) were used to characterize the complexes. © 2011, AIDIC Servizi S.r.l.
2011
978-88-95608-15-0
Petralito, S., Zanardi, I., Memoli, A., Annesini, M.C., Travagli, V. (2011). Cyclodextrin/diacerein inclusion complex: a tool for therapeutic drug delivery. In S. Pierucci (a cura di), Chemical Engineering Transactions (pp. 967-972). Milano : AIDIC SERVIZI SRL [10.3303/CET1124162].
File in questo prodotto:
File Dimensione Formato  
Chemical Engineering Transactions 2011 967-972.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 617.98 kB
Formato Adobe PDF
617.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/13317
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo